Robert E. Gagnon - Net Worth and Insider Trading
Robert E. Gagnon Net Worth
The estimated net worth of Robert E. Gagnon is at least $2 Million dollars as of 2024-12-01. Robert E. Gagnon is the CFO of Harvard Bioscience Inc and owns about 321,169 shares of Harvard Bioscience Inc (HBIO) stock worth over $706,572. Robert E. Gagnon is the Vice President, Finance of Biogen Inc and owns about 3,999 shares of Biogen Inc (BIIB) stock worth over $642,359. Robert E. Gagnon is also the Director of Verastem Inc and owns about 34,892 shares of Verastem Inc (VSTM) stock worth over $186,323. Details can be seen in Robert E. Gagnon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E. Gagnon has not made any transactions after 2024-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert E. Gagnon
Robert E. Gagnon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E. Gagnon owns 4 companies in total, including Verastem Inc (VSTM) , Harvard Bioscience Inc (HBIO) , and Clean Harbors Inc (CLH) among others .
Click here to see the complete history of Robert E. Gagnon’s form 4 insider trades.
Insider Ownership Summary of Robert E. Gagnon
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VSTM | Verastem Inc | 2024-09-19 | Chief Financial Officer |
HBIO | Harvard Bioscience Inc | 2018-08-29 | Chief Financial Officer |
CLH | Clean Harbors Inc | 2012-08-20 | EVP CFO and Treasurer |
2012-02-29 | Chief Acct Officer VP & Contol |
Robert E. Gagnon Latest Holdings Summary
Robert E. Gagnon currently owns a total of 3 stocks. Among these stocks, Robert E. Gagnon owns 321,169 shares of Harvard Bioscience Inc (HBIO) as of August 29, 2018, with a value of $706,572 and a weighting of 46.02%. Robert E. Gagnon owns 3,999 shares of Biogen Inc (BIIB) as of February 29, 2012, with a value of $642,359 and a weighting of 41.84%. Robert E. Gagnon also owns 34,892 shares of Verastem Inc (VSTM) as of September 19, 2024, with a value of $186,323 and a weighting of 12.14%.
Latest Holdings of Robert E. Gagnon
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HBIO | Harvard Bioscience Inc | 2018-08-29 | 321,169 | 2.20 | 706,572 |
BIIB | Biogen Inc | 2012-02-29 | 3,999 | 160.63 | 642,359 |
VSTM | Verastem Inc | 2024-09-19 | 34,892 | 5.34 | 186,323 |
Holding Weightings of Robert E. Gagnon
Robert E. Gagnon Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years. The most-recent trade in Harvard Bioscience Inc is the sale of 8,889 shares on August 29, 2018, which brought Robert E. Gagnon around $51,290.
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,552 shares on February 29, 2012, which brought Robert E. Gagnon around $178,868.
According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 15 transactions in Verastem Inc (VSTM) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Verastem Inc is the sale of 131 shares on September 19, 2024, which brought Robert E. Gagnon around $365.
Insider Trading History of Robert E. Gagnon
- 1
Robert E. Gagnon Trading Performance
GuruFocus tracks the stock performance after each of Robert E. Gagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E. Gagnon is 10.52%. GuruFocus also compares Robert E. Gagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E. Gagnon within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert E. Gagnon's insider trading performs compared to the benchmark.
Performance of Robert E. Gagnon
Robert E. Gagnon Ownership Network
Robert E. Gagnon Owned Company Details
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Robert E. Gagnon is the Chief Financial Officer of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and other: See Explanation of Responses Bvf I Gp Llc .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Robert E. Gagnon made 9 insider transaction in Verastem Inc (VSTM) with a net sale of 20,888. Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 668 shares made by Daniel Calkins , a net sale of 6,617 shares made by Dan Paterson , and a net sale of 4,949 shares made by Brian M Stuglik .
In summary, during the past 3 months, insiders sold 2,695 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,695 shares. During the past 18 months, 33,122 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,122 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
Robert E. Gagnon Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E. Gagnon. You might contact Robert E. Gagnon via mailing address: C/o Biogen Idec Inc., 133 Boston Post Road, Weston Ma 02493.